Cardiac Syndrome X: Update.

[1]  F. Crea,et al.  Coronary microvascular dysfunction in patients without myocardial diseases and obstructive atherosclerosis , 2014 .

[2]  A. Mahajan,et al.  Anesthetic considerations for thoracoscopic sympathetic ganglionectomy to treat ventricular tachycardia storm: a single-center experience. , 2014, Journal of cardiothoracic and vascular anesthesia.

[3]  C. Merz,et al.  Provocative testing for coronary reactivity and spasm. , 2014, Journal of the American College of Cardiology.

[4]  J. Zhao,et al.  Effects of combination of statin and calcium channel blocker in patients with cardiac syndrome X , 2014, Coronary artery disease.

[5]  Daniel S Berman,et al.  Cardiac magnetic resonance imaging myocardial perfusion reserve index assessment in women with microvascular coronary dysfunction and reference controls. , 2013, Cardiovascular diagnosis and therapy.

[6]  John Kelly Wachira,et al.  Cardiovascular disease and bridging the diagnostic gap. , 2013, South Dakota medicine : the journal of the South Dakota State Medical Association.

[7]  Filippo Crea,et al.  Coronary microvascular dysfunction. , 2013, The New England journal of medicine.

[8]  Min Gao,et al.  Sex differences in clinical outcomes in patients with stable angina and no obstructive coronary artery disease. , 2013, American heart journal.

[9]  W. Frishman.  β-Adrenergic Blockade in Cardiovascular Disease , 2013, Journal of cardiovascular pharmacology and therapeutics.

[10]  J. Beltrame,et al.  Chest pain in patients with 'normal angiography': could it be cardiac? , 2013, International journal of evidence-based healthcare.

[11]  J. McConaghy,et al.  Outpatient diagnosis of acute chest pain in adults. , 2013, American family physician.

[12]  F. Crea,et al.  Lack of Effect of Nitrates on Exercise Stress Test Results in Patients with Microvascular Angina , 2013, Cardiovascular Drugs and Therapy.

[13]  A. Parsyan,et al.  Cardiac syndrome X: mystery continues. , 2012, The Canadian journal of cardiology.

[14]  Erik Jørgensen,et al.  Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. , 2012, European heart journal.

[15]  J. Parker,et al.  Stable angina pectoris: the medical management of symptomatic myocardial ischemia. , 2012, The Canadian journal of cardiology.

[16]  R. Fass,et al.  Noncardiac chest pain: diagnostic evaluation. , 2012, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[17]  K. Smith,et al.  In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia , 2011, American heart journal.

[18]  Kamlesh Kothawade,et al.  Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and management. , 2011, Current problems in cardiology.

[19]  Piotr J Slomka,et al.  Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. , 2011, JACC. Cardiovascular imaging.

[20]  Sarabjeet Singh,et al.  Cardiac syndrome X: current concepts. , 2010, International journal of cardiology.

[21]  Dudley J Pennell,et al.  Low diagnostic yield of elective coronary angiography. , 2010, The New England journal of medicine.

[22]  B. Nossaman,et al.  Nitrates and Nitrites in the Treatment of Ischemic Cardiac Disease , 2010, Cardiology in Review.

[23]  R. Ferrari,et al.  Secondary Prevention of CAD with ACE Inhibitors: A Struggle Between Life and Death of the Endothelium , 2010, Cardiovascular Drugs and Therapy.

[24]  F. Crea,et al.  Primary Coronary Microvascular Dysfunction: Clinical Presentation, Pathophysiology, and Management , 2010, Circulation.

[25]  H. W. Christensen,et al.  Chest pain in focal musculoskeletal disorders. , 2010, The Medical clinics of North America.

[26]  C. Cotrim,et al.  Cardiac syndrome X, intraventricular gradients and, beta-blockers. , 2010, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[27]  E. Çakır,et al.  Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X. , 2009, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.

[28]  B. Mandleco,et al.  Chest pain with angiographic clear coronary arteries: A provider's approach to cardiac syndrome X , 2009, Journal of the American Academy of Nurse Practitioners.

[29]  W. Lawson,et al.  Enhanced external counterpulsation is an effective treatment for Syndrome X. , 2009, International journal of cardiology.

[30]  Carl J Pepine,et al.  Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. , 2009, Archives of internal medicine.

[31]  A. Phan,et al.  Persistent chest pain and no obstructive coronary artery disease. , 2009, JAMA.

[32]  R. Donahue,et al.  Ranolazine attenuates behavioral signs of neuropathic pain , 2009, Behavioural pharmacology.

[33]  C. Lang,et al.  Therapeutic development in cardiac syndrome X: a need to target the underlying pathophysiology. , 2009, Cardiovascular therapeutics.

[34]  F. Crea,et al.  Advances in coronary microvascular dysfunction. , 2009, Heart, lung & circulation.

[35]  Lynda Evans,et al.  Cardiac rehabilitation for the treatment of women with chest pain and normal coronary arteries , 2008, Menopause.

[36]  Sonia S. Anand,et al.  Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. , 2008, European heart journal.

[37]  L. Pilote,et al.  Angina with "normal" coronary arteries: sex differences in outcomes. , 2008, American heart journal.

[38]  Filippo Crea,et al.  Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. , 2008, Journal of the American College of Cardiology.

[39]  J. O’Keefe,et al.  Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. , 2008, Journal of the American College of Cardiology.

[40]  M. Staal,et al.  The sustained benefits of long‐term neurostimulation in patients with refractory chest pain and normal coronary arteries , 2007, European journal of pain.

[41]  D. Groves,et al.  A brief cognitive-behavioral intervention reduces hospital admissions in refractory angina patients. , 2007, Journal of pain and symptom management.

[42]  S. Reis,et al.  Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) , 2007, Clinical cardiology.

[43]  W. Ferrell,et al.  Microvascular function, metabolic syndrome, and novel risk factor status in women with cardiac syndrome X. , 2006, The American journal of cardiology.

[44]  D. Groves,et al.  Temporary sympathectomy in the treatment of chronic refractory angina. , 2005, Journal of pain and symptom management.

[45]  C. Apovian,et al.  Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. , 2005, The American journal of cardiology.

[46]  E. Picano,et al.  Effect of simvastatin on endothelial function in cardiac syndrome X patients. , 2004, The American journal of cardiology.

[47]  B. Chaitman,et al.  Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. , 2004, Journal of the American College of Cardiology.

[48]  Filippo Crea,et al.  Angina pectoris and normal coronary arteries: cardiac syndrome X , 2004, Heart.

[49]  K. Smith,et al.  Abnormal Coronary Vasomotion as a Prognostic Indicator of Cardiovascular Events in Women: Results From the National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) , 2004, Circulation.

[50]  B. Chaitman,et al.  Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. , 2004, JAMA.

[51]  M. Kayıkçıoğlu,et al.  Benefits of statin treatment in cardiac syndrome-X1. , 2003, European heart journal.

[52]  L. Dobrucki,et al.  Third-Generation &bgr;-Blockers Stimulate Nitric Oxide Release From Endothelial Cells Through ATP Efflux: A Novel Mechanism for Antihypertensive Action , 2003, Circulation.

[53]  Shing‐Jong Lin,et al.  Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. , 2002, The American journal of cardiology.

[54]  C. Sylvén,et al.  Beneficial therapeutic effects of physical training and relaxation therapy in women with coronary syndrome X. , 2002, Physiotherapy research international : the journal for researchers and clinicians in physical therapy.

[55]  C. Vassanelli,et al.  Evidence of parasympathetic impairment in some patients with cardiac syndrome X. , 2001, Cardiovascular research.

[56]  K. Matthews,et al.  History of anxiety disorders is associated with a decreased likelihood of angiographic coronary artery disease in women with chest pain: the WISE study. , 2001, Journal of the American College of Cardiology.

[57]  F. Crea,et al.  Myocardial ischemia-reperfusion damage after pacing-induced tachycardia in patients with cardiac syndrome X. , 2000, American journal of physiology. Heart and circulatory physiology.

[58]  M. Jensen-Urstad,et al.  Physical training in Syndrome X: physical training counteracts deconditioning and pain in Syndrome X. , 2000, Journal of the American College of Cardiology.

[59]  N. Reichek,et al.  Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. , 2000, The New England journal of medicine.

[60]  G. Rosano,et al.  Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance. , 1999, Cardiologia.

[61]  T. Jensen,et al.  Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action , 1999, PAIN®.

[62]  A. Maseri,et al.  Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. , 1999, The American journal of cardiology.

[63]  R. Nesto,et al.  The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. , 1999, Journal of the American College of Cardiology.

[64]  A. Maseri,et al.  Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. , 1999, Journal of the American College of Cardiology.

[65]  P. Camici,et al.  Endothelium-dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X. , 1999, Circulation.

[66]  O. Raitakari,et al.  Arterial Endothelial Dysfunction Related to Passive Smoking Is Potentially Reversible in Healthy Young Adults , 1999, Annals of Internal Medicine.

[67]  E. Johnstone,et al.  Group psychological treatment for chest pain with normal coronary arteries. , 1999, QJM : monthly journal of the Association of Physicians.

[68]  J. Kaski,et al.  Low dose imipramine improves chest pain but not quality of life in patients with angina and normal coronary angiograms. , 1998, European heart journal.

[69]  S. Nalbantgil,et al.  Therapeutic Benefits of Cilazapril in Patients with Syndrome X , 1998, Cardiology.

[70]  P. Elliott,et al.  Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X). , 1997, Heart.

[71]  A. Quyyumi,et al.  Investigation of the mechanism of chest pain in patients with angiographically normal coronary arteries using transesophageal dobutamine stress echocardiography. , 1997, Journal of the American College of Cardiology.

[72]  S. Yeh,et al.  Effective therapy with transthoracic video-assisted endoscopic coagulation of the left stellate ganglion and upper sympathetic trunk in congenital long-QT syndrome. , 1996, American heart journal.

[73]  P. Poole‐Wilson,et al.  Failure to demonstrate myocardial ischaemia in patients with angina and normal coronary arteries. Evaluation by continuous coronary sinus pH monitoring and lactate metabolism. , 1996, European heart journal.

[74]  O. Hess,et al.  Effect of diltiazem on coronary flow reserve in patients with microvascular angina. , 1995, International journal of cardiology.

[75]  H. Crijns,et al.  Mechanisms of angina pectoris in syndrome X assessed by myocardial perfusion dynamics and heart rate variability. , 1995, European heart journal.

[76]  H. Bøtker,et al.  Autonomic balance in patients with angina and a normal coronary angiogram. , 1995, European heart journal.

[77]  J. Taki,et al.  Effects of short-term aminophylline administration on cardiac functional reserve in patients with syndrome X. , 1995, Journal of the American College of Cardiology.

[78]  P A Poole-Wilson,et al.  Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. , 1995, Journal of the American College of Cardiology.

[79]  A. Yeung,et al.  The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. , 1995, The New England journal of medicine.

[80]  D. Tousoulis,et al.  Coronary Vasodilator Reserve, Pain Perception, and Sex in Patients With Syndrome X , 1994, Circulation.

[81]  A. Quyyumi,et al.  Imipramine in patients with chest pain despite normal coronary angiograms. , 1994, The New England journal of medicine.

[82]  K. Fox,et al.  Chest pain in women: clinical, investigative, and prognostic features , 1994, BMJ.

[83]  G. Rosano,et al.  Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina. , 1994, Journal of the American College of Cardiology.

[84]  A. Lammertsma,et al.  Comparison of regional myocardial blood flow in syndrome X and one-vessel coronary artery disease. , 1993, The American journal of cardiology.

[85]  C. Sylvén,et al.  Lower threshold for adenosine-induced chest pain in patients with angina and normal coronary angiograms , 1992, British heart journal.

[86]  A. L'Abbate,et al.  Coronary Reserve and Exercise ECG in Patients With Chest Pain and Normal Coronary Angiograms , 1992, Circulation.

[87]  I. Hutton,et al.  Thallium scans in syndrome X , 1992, British heart journal.

[88]  B. Beitman,et al.  Panic disorder in patients with angiographically normal coronary arteries. , 1992, The American journal of medicine.

[89]  P. Nihoyannopoulos,et al.  Absence of myocardial dysfunction during stress in patients with syndrome X. , 1991, Journal of the American College of Cardiology.

[90]  E. Ferrannini,et al.  Coronary hemodynamics and myocardial metabolism in patients with syndrome X: response to pacing stress. , 1991, Journal of the American College of Cardiology.

[91]  F. Crea,et al.  Mechanisms of angina pectoris in syndrome X. , 1991, Journal of the American College of Cardiology.

[92]  A. Quyyumi,et al.  Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries. , 1990, Journal of the American College of Cardiology.

[93]  M. Emdin,et al.  Improved exercise capacity with acute aminophylline administration in patients with syndrome X. , 1989, Journal of the American College of Cardiology.

[94]  P. Puddu,et al.  Comparison of verapamil versus propranolol therapy in syndrome X. , 1989, The American journal of cardiology.

[95]  P. Poole‐Wilson,et al.  Is altered cardiac sensation responsible for chest pain in patients with normal coronary arteries? Clinical observation during cardiac catheterisation , 1988, British medical journal.

[96]  F. Harrell,et al.  Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries. , 1986, The American journal of cardiology.

[97]  F. Crea,et al.  Transient myocardial ischemia during daily life in patients with syndrome X. , 1986, The American journal of cardiology.

[98]  R. Kronmal,et al.  Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study. , 1986, Journal of the American College of Cardiology.

[99]  R. Cannon,et al.  Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve. , 1985, The American journal of cardiology.

[100]  A. Maseri,et al.  Efficacy of carvedilol (BM 14,190), a new beta-blocking drug with vasodilating properties, in exercise-induced ischemia. , 1985, The American journal of cardiology.

[101]  T. Haney,et al.  Unimproved chest pain in patients with minimal or no coronary disease: a behavioral phenomenon. , 1984, American heart journal.

[102]  A. Moss,et al.  Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome. , 1971, The New England journal of medicine.

[103]  J. Kaski,et al.  Mechanisms of Angina Pectoris in Syndrome , 2016 .

[104]  J. Beltrame.  Defining the coronary slow flow phenomenon. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[105]  B. De Bruyne,et al.  The pathophysiology and clinical course of the normal coronary angina syndrome (cardiac syndrome X). , 2008, Progress in cardiovascular diseases.

[106]  PhD Christer Drott MD.  Results of endoscopic thoracic sympathectomy (ETS) on hyperhidrosis, facial blushing, angina pectoris, vascular disorders and pain syndromes of the hand and arm , 2003, Clinical Autonomic Research.

[107]  Onathan R. P Anting,et al.  ABNORMAL SUBENDOCARDIAL PERFUSION IN CARDIAC SYNDROME X DETECTED BY CARDIOVASCULAR MAGNETIC RESONANCE IMAGING , 2002 .

[108]  F. Crea,et al.  Spinal cord stimulation in patients with refractory anginal pain and normal coronary arteries. , 2001, Italian heart journal : official journal of the Italian Federation of Cardiology.

[109]  J Czernin,et al.  Endothelium-dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X. , 1999, Circulation.

[110]  F. Crea,et al.  Role of abnormal pain sensitivity and behavioral factors in determining chest pain in syndrome X. , 1998, Journal of the American College of Cardiology.

[111]  F. Crea,et al.  Effects of bamiphylline on exercise testing in patients with syndrome X. , 1997, Giornale italiano di cardiologia.

[112]  F. Crea,et al.  Ischemic-like ST-segment changes during Holter monitoring in patients with angina pectoris and normal coronary arteries but negative exercise testing. , 1997, The American journal of cardiology.

[113]  M. Petch,et al.  Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoris and normal coronary angiograms. , 1997, European heart journal.

[114]  A. Timmis,et al.  THALLIUM SCANS IN SYNDROME X. REPLIES , 1992 .

[115]  H. Kemp.  Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. , 1973, The American journal of cardiology.